MedPage Today

Does Breast Density Increase Risk of Re-excision After Breast-Conservation Surgery?

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with dense breast tissue may have a less accurate ...
Nature

Close or positive margins in breast-conserving surgery: is re-excision always necessary?

A recent study by Chism and co-workers has addressed some of the controversies surrounding the importance of margin status and re-excision in breast-conserving treatment for early breast cancer. Given ...
Healio

Recurrence rates lower for re-excision of basal cell carcinoma vs. clinical follow-up

Please provide your email address to receive an email when new articles are posted on . MILAN — Patients who underwent re-excision for positive margins after incomplete surgery for basal cell ...
ascopubs.org

Audit of indications and rate of re-excision following breast-conserving surgery within a multidisciplinary cancer network (Sussex, Surrey, and West Hampshire [SWSH]) in the ...

Cost-effectiveness of letrozole (LET) versus anastrozole (ANA) in postmenopausal women (PMW) with hormone receptor-positive (HR+) early-stage breast cancer (EBC) based on indirect comparison of BIG ...
Medscape

Re-excision Rates Plummet After Negative Margin Guideline

CHICAGO — Rates of re-excision and conversion to mastectomy after initial lumpectomy in women with early invasive breast cancer dropped dramatically after the release of a 2014 consensus guideline ...
EurekAlert!

Re-excision rates after breast-conserving surgery pose ongoing challenges in the US: UTHealth Houston study unveils high reoperation rates and costs

Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative ...
ascopubs.org

Long-term results of primary re-excision after unplanned resection of a soft tissue sarcoma of the extremities and trunk.

Neoadjuvant, adjuvant, and palliative treatment with imatinib in patients with gastrointestinal stromal tumors. Background: Soft tissue sarcomas are often treated by inadequate resection lacking ...